You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
豬瘟疫苗板塊開盤大漲 非洲豬瘟疫苗創制成功
格隆匯 03-02 09:33

格隆匯3月2日丨豬瘟疫苗板塊開盤大漲,普萊柯、蔚藍生物一字漲停,中牧股份漲超6%,生物股份、海利生物等集體高開。

消息面上,中國農業科學院哈爾濱獸醫研究所在《中國科學:生命科學》英文版在線發表研究論文,報道了一株人工缺失七個基因的非洲豬瘟弱毒活疫苗對家豬具有良好的安全性和有效性。

非洲豬瘟是由非洲豬瘟病毒(ASFV)引起的一種急性、烈性、高度接觸性傳染病,發病率和致死率可高達100%,給全球養豬業造成嚴重影響。非洲豬瘟自2018年8月以來在全國範圍內大規模爆發流行,使我國生豬出欄量減少40%,豬肉價格翻了一倍。依靠生物安全和撲殺措施控制非洲豬瘟難度極大,迫切需要研發有效疫苗。

該疫苗是目前最具實現產業化應用前景的疫苗,將為我國及有關國家非洲豬瘟疫情的有效防控提供重要技術手段。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account